Campbell & CO Investment Adviser LLC Galapagos Nv Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$24.78 - $32.48 $492,700 - $645,799
19,883 New
19,883 $492,000
Q4 2022

Feb 14, 2023
SELL
$37.44 - $46.51 $337,222 - $418,915
-9,007 Reduced 57.96%
6,534 $289,000
Q3 2022

Nov 14, 2022
BUY
$42.27 - $57.6 $656,918 - $895,161
15,541 New
15,541 $663,000
Q1 2020

Apr 29, 2020
SELL
$143.0 - $274.03 $379,093 - $726,453
-2,651 Closed
0 $0
Q4 2019

Jan 23, 2020
BUY
$146.12 - $215.82 $387,364 - $572,138
2,651 New
2,651 $548,000

Others Institutions Holding GLPG

# of Institutions
84
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email